Molecular sieve SCM-15, synthesis method therefor and use thereof

US10974967B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10974967-B2
Application numberUS-201716622795-A
CountryUS
Kind codeB2
Filing dateOct 31, 2017
Priority dateJun 13, 2017
Publication dateApr 13, 2021
Grant dateApr 13, 2021

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The invention relates to a molecular sieve SCM-15, a preparation process and use thereof. The molecular sieve comprises a schematic chemical composition of a formula of “SiO 2 .GeO 2 ”, wherein the molar ratio of silicon and germanium satisfies SiO 2 /GeO 2 ≥1. The molecular sieve has unique XRD diffraction data and can be used as an adsorbent or a catalyst.

First claim

Opening claim text (preview).

The invention claimed is: 1. A molecular sieve SCM 15 in its prepared form or calcined form, has an X-ray diffraction spectrum substantially as shown in Table A-1 or Table A-2 below, TABLE A-1 2θ (°) (a) d-distance (Å) (b) Relative intensity (I/I 0 × 100) 4.811 18.353 w 6.571 13.441 m-vs 6.888 12.823 m-s 9.675 9.134 m-vs 9.894 8.933 m-vs 19.888 4.461 w-m (a) = ±0.3°, (b) is a function of 2θ, TABLE A-2 2θ (°) (a) d-distance (Å) Relative intensity (I/I 0 × 100) 4.811 18.424 ± 1.148 w 6.571 13.468 ± 0.614 m-vs 6.888 12.847 ± 0.559 m-s 9.675  9.143 ± 0.283 m-vs 9.894  8.941 ± 0.270 m-vs 19.888  4.462 ± 0.067 w-m (a)= ±0.3°. 2. The molecular sieve SCM-15 according to claim 1 , wherein the X-ray diffraction spectrum further comprises X-ray diffraction peaks substantially as shown in Table B-1 or Table B-2 below, TABLE B-1 2θ (°) (a) d-distance (Å) (b) Relative intensity (I/I 0 × 100) 8.225 10.741 W 15.592 5.679 W 22.031 4.031 w-m 22.435 3.960 w-m 25.330 3.513 W (a) = ±0.3°, (b) is a function of 2θ, TABLE B-2 2θ (°) (a) d-distance (Å) Relative intensity (I/I 0 × 100) 8.225 10.755 ± 0.392  W 15.592 5.681 ± 0.109 W 22.031 4.032 ± 0.054 w-m 22.435 3.960 ± 0.052 w-m 25.330 3.514 ± 0.041 W (a) = ±0.3°, said X-ray diffraction spectrum optionally further comprising X-ray diffraction peaks substantially as shown in the table below, 2θ (°) (a) d-distance (Å) Relative intensity (I/I 0 × 100) 14.294 6.194 ± 0.129   W 16.909

Assignees

Inventors

Classifications

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10974967B2 cover?
The invention relates to a molecular sieve SCM-15, a preparation process and use thereof. The molecular sieve comprises a schematic chemical composition of a formula of “SiO 2 .GeO 2 ”, wherein the molar ratio of silicon and germanium satisfies SiO 2 /GeO 2 ≥1. The molecular sieve has unique XRD diffraction data and can be used as an adsorbent or a catalyst.
Who is the assignee on this patent?
China Petroleum & Chem Corp, Shanghai Res Inst Petrochemical Tech Sinopec
What technology area does this patent fall under?
Primary CPC classification C01B39/48. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Apr 13 2021 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 2 related publications on this page (citations in our corpus or others sharing the same primary CPC).